COGNITION THERAPEUTICS INC (CGTX) Stock Analyst Earnings Estimates
NASDAQ:CGTX - Nasdaq - US19243B1026 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 443.53% | N/A 81.59% | N/A 49.58% | N/A 36.75% | |||||||
| EBITDA YoY % growth | -17.75M | -17.31M 2.48% | -28.51M -64.70% | -43.47M -52.47% | -50.472M -16.11% | -53.7M -6.40% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -17.83M | -17.41M 2.36% | -28.6M -64.27% | -43.55M -52.27% | -50.724M -16.47% | -53.966M -6.39% | N/A -1.90% | N/A -26.60% | N/A -48.85% | N/A -75.29% | N/A 19.60% | N/A 31.15% | N/A 89.45% | N/A 1,119.23% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -0.91 45.60% | -0.86 5.49% | -0.87 -1.16% | N/A 51.93% | N/A 31.71% | N/A 7.14% | N/A | N/A 38.46% | N/A 43.75% | N/A 88.89% | N/A 900.00% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 39.55% | -0.09 63.28% | -0.09 48.00% | -0.05 63.57% |
| Revenue Q2Q % growth | N/A | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.2M 30.51% | -7.14M 50.63% | -9.18M 14.39% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.14 48.15% | -0.11 | -0.03 | -24.49% |
| Q4 2024 Q2Q % growth | -0.17 37.04% | -0.14 | -0.03 | -17.37% |
| Q3 2024 Q2Q % growth | -0.25 -13.64% | -0.23 | -0.02 | -8.93% |
| Q2 2024 Q2Q % growth | -0.18 -12.50% | -0.24 | 0.06 | 25.17% |
| Q1 2024 Q2Q % growth | -0.27 -28.57% | -0.25 | -0.02 | -7.31% |
| Q4 2023 Q2Q % growth | -0.27 -35.00% | -0.35 | 0.08 | 22.60% |
| Q3 2023 Q2Q % growth | -0.22 24.14% | -0.24 | 0.02 | 8.70% |
| Q2 2023 Q2Q % growth | -0.16 36.00% | -0.19 | 0.03 | 17.00% |
| Q1 2023 Q2Q % growth | -0.21 -23.53% | -0.18 | -0.03 | -17.43% |
| Q4 2022 Q2Q % growth | -0.20 98.30% | -0.23 | 0.03 | 12.66% |
| Q3 2022 Q2Q % growth | -0.29 96.43% | -0.39 | 0.10 | 25.96% |
| Q2 2022 Q2Q % growth | -0.25 | -0.33 | 0.08 | 23.72% |
| Q1 2022 Q2Q % growth | -0.17 | -0.29 | 0.12 | 41.86% |
| Q4 2021 Q2Q % growth | -11.74 | -0.26 | -11.48 | -4,335.38% |
| Q3 2021 Q2Q % growth | -8.12 | -0.58 | -7.54 | -1,296.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1.46% | 0% | -1.05% |
| Revenue | N/A | N/A | N/A | N/A |